13 May 2022 10:05
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Posting of Circular and Notice of General Meeting
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, announces, further to the announcement of 6 May 2022, a Circular containing details of the Open Offer and convening the General Meeting, together with a Form of Proxy will be posted to Shareholders today.
The General Meeting will be held at the offices of Shepherd & Wedderburn, 1 Exchange Crescent, Conference Square, Edinburgh, EH3 8UL at 11.00 a.m. on 6 June 2022. A copy of the Circular will today be made available on the Company's website: http://www.omegadiagnostics.com/Investor-Relations/Corporate-Information
Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's announcement dated 6 May 2022.
Contacts:
Omega Diagnostics Group PLC | www.omegadx.com | ||
Jag Grewal, Chief Executive Officer | via Walbrook PR | ||
Chris Lea, Chief Financial Officer | |||
finnCap Ltd | Tel: 020 7220 0500 | ||
Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance) | |||
Alice Lane/ Harriet Ward (ECM) | |||
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com | ||
Paul McManus | Mob: 07980 541 893 | ||
Lianne Applegarth | Mob: 07584 391 303 | ||
Sam Allen | Mob: 07502 558 258 | ||
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health.
www.omegadx.com
ODX.L (ODX)